A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2
Crossref DOI link: https://doi.org/10.1007/s10571-016-0349-0
Published Online: 2016-03-02
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Cui’e
Shi, Linyu
Sun, Bei
Zhang, Yu
Hou, Bailing
Sun, Yu’e
Ma, Zhengliang
Gu, Xiaoping
Text and Data Mining valid from 2016-03-02